Literature DB >> 13770726

Ventricular endomyocardial pathology produced by chronic cardiac lymphatic obstruction in the dog.

A J MILLER, R PICK, L N KATZ.   

Abstract

Entities:  

Keywords:  LYMPHATIC SYSTEM/pathology; MYOCARDIUM/pathology

Mesh：

Year:  1960        PMID： 13770726     DOI： 10.1161/01.res.8.5.941

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

1.  [Diseases of the parietal endocardium with special reference to their pathologic anatomy].

Authors:  W REMMELE
Journal:  Klin Wochenschr       Date:  1962-04-15

2.  VENTRICULAR ENDOMYOCARDIAL CHANGES AFTER IMPAIRMENT OF CARDIAC LYMPH FLOW IN DOGS.

Authors:  A J Miller; R Pick; L N Katz; C Jones; J Rodgers
Journal:  Br Heart J       Date:  1963-03

3.  Primary endocardial fibroelastosis of the left ventricle.

Authors:  Albert J Miller
Journal:  Tex Heart Inst J       Date:  2012

4.  Experimental development of cardiac transplantation.

Authors:  D K Cooper
Journal:  Br Med J       Date:  1968-10-19

5.  [Distribution of the lymph vessels in the mouse heart. A light and electron microscopic study (author's transl)].

Authors:  A Böger; W Hort
Journal:  Basic Res Cardiol       Date:  1977 Sep-Oct       Impact factor: 17.165

6.  Dilated cardiomyopathy with endocardial fibroelastosis in a juvenile Pallas cat.

Authors:  Erwin K Gudenschwager; Jonathan A Abbott; Tanya LeRoith
Journal:  J Vet Diagn Invest       Date:  2019-01-29       Impact factor: 1.279

7.  Alteration of epicardial lymphatics in lymphostatic canine hearts.

Authors:  E Okada
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

8.  A murine model of increased coronary sinus pressure induces myocardial edema with cardiac lymphatic dilation and fibrosis.

Authors:  Natalie R Nielsen; Krsna V Rangarajan; Lan Mao; Howard A Rockman; Kathleen M Caron
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-06       Impact factor: 4.733

Review 9.  ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease.

Authors:  Dong Hun Lee; Tae Min Kim; Joo Kyung Kim; Changwon Park
Journal:  Theranostics       Date:  2019-08-09       Impact factor: 11.556
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.